Abstract:Persistent antigen exposure during chronic hepatitis B infection leads to exhausted immune responses, thus impeding viral control. In recent years, immunometabolism opens new therapeutic possibilities for the modulation of immune responses. Herein, we investigated the immunomodulatory effect of L-carnitine (L-Cn) on immune cells in chronic HBV infection. In this study, 141 treatment-naïve patients with chronic HBV infection, 38 patients who achieved HBsAg loss following antiviral treatment, and 47 patients who suffered from HBV-related HCC from real-life clinical practice were recruited. The plasma L-Cn levels were measured by ELISA. RNA sequencing was conducted to define the transcriptional profiles of peripheral blood mononuclear cells after L-Cn stimulation. In vitro assays were performed to assess the effect of L-Cn on immune cells; the frequencies and function of immune cells were analyzed by flow cytometry. We found that compared with patients with HBsAg loss, patients with HBsAg positivity and patients who suffered from HBV-related HCC had higher levels of L-Cn, and the plasma levels of L-Cn in the HBeAg-positive chronic hepatitis patients who had elevated ALT were significantly higher than that of HBeAg-negative chronic infection and HBsAg loss groups. Moreover, a positive correlation between plasma levels of L-Cn and HBsAg levels was found. Additionally, RNA sequencing analysis demonstrated that L-Cn altered the transcriptional profiles related to immune response. In vitro assays revealed that L-Cn suppressed the proliferation of and IFN-γ production by CD4+ and CD8+ T cells. It also down-regulated the proliferation and IgG production of B cells. Notably, L-Cn enhanced IL-10 secretion from regulatory T cells and up-regulated the expression of inhibitory receptors on T cells. Moreover, a variant in CPT2 (rs1799821) was confirmed to be associated with L-Cn levels as well as complete response in CHB patients following Peg-IFNα antiviral therapy. Taken together, the immunosuppressive properties of L-Cn may hinder the control of HBV in chronic HBV infection, implicating that L-Cn manipulation might influence the prognosis of patients with HBV infection.

In Vitro Antiviral Activity of Lutein Against Hepatitis B Virus

Increasing LAG-3 Expression Suppresses T-cell Function in Chronic Hepatitis B

Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-mediated Down-regulation of Hepatocyte Nuclear Factor 4α Expression.

Luteolin-7-O-Glucoside Present in Lettuce Extracts Inhibits Hepatitis B Surface Antigen Production and Viral Replication by Human Hepatoma Cells in Vitro

High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection

Clinical and Experimental Effectiveness of Astragali Compound in the Treatment of Chronic Viral Hepatitis B

In vitro evaluation on the effects of Astragalus and Thoroughfare decoction against hepatitis B virus

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model

In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients

In Vitro Antiviral Activity of Three Enantiomeric Sesquiterpene Lactones from Senecio Species Against Hepatitis B Virus.

Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library

Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes

Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon Α.

In vitro inhibition effects of hepatitis B virus by dandelion and taraxasterol

Hepatitis B Virus Inhibition in Mice by Lentiviral Vector Mediated Short Hairpin RNA.

In Vitro Anti-Hepatitis B Virus Effect of Hypericum Perforatum L.

Inhibition Efficacy of Tenofovir on Hepatitis B Virus in Vitro

In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates

Research progress on antiviral effect and mechanism of luteolin

Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion

Effect of iron saturation of bovine lactoferrin on the inhibition of hepatitis B virus in vitro